LSE:AZN
LSE:AZNPharmaceuticals

Assessing AstraZeneca’s Value After Recent Pipeline Developments and Strategic Partnerships

Curious if AstraZeneca is actually a bargain, or if the share price is already factoring in all the good news? Many investors wonder whether now is the right moment to get in or take profits, and we’re about to break it down together. Despite some short-term wobbles, with the stock down 0.5% in the last week and -1.4% for the month, AstraZeneca’s stock has still returned 17.3% year-to-date and 65.0% over the last five years. Recent headlines have emphasized AstraZeneca’s ongoing pipeline...
LSE:PHAR
LSE:PHAROil and Gas

Begbies Traynor Group Leads The Charge With These 3 UK Penny Stocks

The UK stock market has been experiencing turbulence, with the FTSE 100 index closing lower due to weak trade data from China, highlighting challenges in global economic recovery. Amidst these broader market fluctuations, investors often seek opportunities in smaller companies that exhibit strong financial health and growth potential. Penny stocks, though an older term, still capture attention for their affordability and promise when backed by solid fundamentals. In this context, we'll...